Source: Eur Respir J, 56 (5) 2002425; 10.1183/13993003.02425-2020
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
José M. Porcel. PILOTing towards a RAPID predictor of mortality for infectious pleural effusions. Eur Respir J, 56 (5) 2002425; 10.1183/13993003.02425-2020

Member's Comments

No comment yet.

Related content which might interest you: Pleural empyema in hospitalization and mortality risk: application of RAPID score. Source: Virtual Congress 2021 – Bronchiectasis and pleural infection Year: 2021 Intrahospital mortality after pleurodesis for malignant pleural effusion Source: Eur Respir J 2004; 24: Suppl. 48, 629s Year: 2004 Risk stratifying pleural infection using RAPID score in an Asian population Source: Virtual Congress 2021 – Bronchiectasis and pleural infection Year: 2021 The effect of a pleural diseases clinic on pleural effusion admission rates Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions Year: 2012 What is the incidence of pleural effusions in acute pulmonary emboli? Source: Virtual Congress 2020 – Pulmonary embolism Year: 2020 Accuracy of pleural fluid c-reactive protein in differentiating between tuberculous and malignant pleural effusions: a meta-analysis Source: International Congress 2019 – Tuberculosis and comorbidities Year: 2019 Predictors of outcome in parapneumonic pleural effusions in children Source: Eur Respir J 2001; 18: Suppl. 33, 171s Year: 2001 Correlation of accompanying pleural effusion with patient characteristics and mortality in patients with community acquired pneumonia Source: Annual Congress 2007 - Community-acquired pneumonia: from aetiology to complication Year: 2007 Predictive factors, microbiology and outcome of patients with parapneumonic effusion Source: Eur Respir J 2011; 38: 1173-1179 Year: 2011 Parapneumonic pleural effusion as a cause of hypoalbumunemia in pediatric patients Source: Eur Respir J 2006; 28: Suppl. 50, 309s Year: 2006 Talc pleurodesis in malignant pleural effusions: A 5-year experience Source: Annual Congress 2012 - Medical access to the pleura Year: 2012 Risk factors for parapneumonic effusion in community-asquired pneumonia Source: International Congress 2019 – Pleural infection and complicated pneumonia Year: 2019 Audit of success rate and complications of talc slurry pleurodesis for malignant pleural effusions Source: Annual Congress 2008 - Pleural diseases and interventions Year: 2008 The value of adenosin-deaminase in etiologic diagnosis of pleural effusions Source: Eur Respir J 2002; 20: Suppl. 38, 167s Year: 2002 Procalcitonin in pleural fluid: A new tool for the diagnosis of empyema and parapneumonic pleural effusions? Source: Annual Congress 2011 - New aspects in prevention and treatment of community-acquired pneumonia and lower respiratory tract infections Year: 2011 Incidence of lung entrapment in malignant pleural effusion Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions Year: 2012 Mortality and bacteriology in pleural empyema Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia Year: 2009 The management of benign non-infective pleural effusions Source: Eur Respir Rev 2016; 25: 303-316 Year: 2016 Empyema and parapneumonic pleural effusion. Prognostic factors about 109 patients Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers Year: 2009